Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The MSD DPhil Day is an annual symposium showcasing the best student work from across the largest division of the University of Oxford. This year was no exception, and on Friday 20th July students from a wide range of scientific backgrounds came together to display their work to a uniquely broad audience.

Thirteen short talks and forty posters were presented and judged by generous volunteer post-docs. Because the overall quality of submissions was very high, it was difficult to pick winners. However, those awarded prizes generally combined rigorous and creative science with excellent communication skills.

In between short talks, a lively panel discussion was chaired by Afsie Sabokbar which focussed largely on the future of scientific publishing, with contributions from past and present editors of Science, The Lancet, and BMJ. We thank our panellists for their impassioned contributions and empathy for students.

The day closed with a keynote speech from Professor Kevin Marsh, senior advisor to the African Academy of Sciences and winner of numerous prizes for his contributions to health in Africa. Professor Marsh used his speech to challenge common misconceptions about the continent. He outlined the rapid socioeconomic change ongoing, and discussed the development of local scientific infrastructure.

The Committee would like to thank all students who attended and especially those who shared their work. Special thanks is also due to Louise Samson, Amanda King, Afsie Sabokbar. 

2018 DPhil day2.jpgBest talks: 1st prize Lisa Simpson (Division of Cardiovascular Medicine, RDM, pictured)

2nd prize Laura Grima (Nuffield Department of Clinical Neurosciences and Experimental Psychology)

Best posters: 1st prize Valentina Gifford (The Kennedy Institute, NDORMS)

2nd prize Rose Hodgson (Centre for Cellular and Molecular Physiology, NDM)

Committee: Caitlin O’Brian Ball, Robert Donat, Deniz Gursul, Ryan Hoyle, Di Hu, Delphine Nzelle Kayem, Peter Liu, Jeff Liu, Jolynne Mokaya, Becky Im, Xanita Saayman, Paolo Spingardi, Sandeep Unwith

 

Similar stories

General anaesthesia should be available for dying patients - medical and ethical experts

General Research

General anaesthesia should be more widely available for patients at the end of their lives, according to Oxford experts in ethics and anaesthesia, according to a paper published by Anaesthesia (a journal of the Association of Anaesthetists).

Human challenge trial launches to study immune response to COVID-19

Clinical Trials Coronavirus COVID-19 General

Though the COVID-19 pandemic has now been active for a year, not much is known about what happens when people who have already had COVID-19 are infected for a second time.

Alternating vaccines trial expands to include two additional vaccines

Clinical Trials Coronavirus COVID-19 General

Researchers running the Com-Cov study, launched in February to investigate alternating doses of the Oxford-AstraZeneca vaccine and the Pfizer vaccine, have today announced that the programme will be extended to include the Moderna and Novavax vaccines in a new study.

Oxford medical students launch flagship raffle in aid of NHS heroes and lifesaving medical equipment

General

Tingewick, a society formed of medical students from Oxford University, are hosting a virtual charity raffle. With over 70 amazing prizes, ranging from Truck festival tickets to restaurant vouchers to bags of books and even a bike, the raffle is an exciting way to celebrate lockdown lifting by supporting many wonderful Oxfordshire businesses whilst raising lots of money for charity.

UK and EU regulators conclude benefits of vaccination continue to outweigh the risks

Coronavirus COVID-19 General

Today, the medical regulators in the UK and Europe have announced their conclusions from their reviews of very rare cases of unusual blood clots in people who have received the Oxford-AstraZeneca coronavirus vaccine.